US 12378245
Crystalline forms of an RSK inhibitor
granted A61PA61P35/00
Quick answer
US patent 12378245 (Crystalline forms of an RSK inhibitor) held by PHOENIX MOLECULAR DESIGNS expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PHOENIX MOLECULAR DESIGNS
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P35/00